Skip to content
The Policy VaultThe Policy Vault

Eucrisa (crisaborole) — Blue Cross Blue Shield of Alabama

atopic dermatitis (AD)

Initial criteria

  • ONE of the following must be met:
  • - The requested agent is for use on the face (including eyelids), neck, or skin folds (e.g., groin, armpit/under arm)
  • OR
  • - The patient’s medication history includes use of a topical corticosteroid or topical corticosteroid combination preparation within the past 120 days
  • OR
  • - The patient has an intolerance or hypersensitivity to a topical corticosteroid or topical corticosteroid combination preparation
  • OR
  • - The patient has an FDA labeled contraindication to ALL topical corticosteroids and topical corticosteroid combination preparations

Approval duration

12 months